In a twist that could make even the most seasoned virologist raise an eyebrow, patients are now reporting symptoms akin to having “razor blades” in their throats, a phenomenon dubbed the ‘razor throat’ by healthcare professionals. What a delightful addition to the COVID-19 symptom repertoire!
Emerging from the depths of China’s ongoing pandemic struggles, the COVID-19 variant responsible for this sharp increase in cases has now made its way to at least 15 states across the United States, as noted by a private tracking firm.
Just earlier this week, doctors in China forecasted a peak in COVID-19 cases for July, driven primarily by the variant known as NB.1.8.1, which is currently the leading cause of rising infections in the mainland. This variant seems to have taken a page from a horror novel, with its sharp throat symptoms that have become a talking point among patients and health experts alike.
Geographic Spread of the New Strain
As of June 19, the NB.1.8.1 strain has been identified in a plethora of states, including Arizona, California, Colorado, New Jersey, New York, Hawaii, Illinois, Maryland, Massachusetts, Ohio, Rhode Island, Utah, Vermont, Virginia, and Washington state, as illustrated by data from the Global Initiative on Sharing All Influenza Data.
According to recent statistics from the Centers for Disease Control and Prevention (CDC), this variant accounts for about 37 percent of all current cases, a significant leap considering it was not even on their radar just weeks ago. Now, it stands as the runner-up to another variant, LP.8.1.
In a statement last month, the CDC acknowledged awareness of reported cases of COVID-19 NB.1.8.1 in China and confirmed it is maintaining regular communication with international health partners. We can only hope this vigilance translates into effective action.
Severity Assessment
The World Health Organization (WHO) reports that the current surge in cases is mainly concentrated in the eastern Mediterranean, Southeast Asia, and western Pacific regions. Most notably, they noted that the NB.1.8.1 variant constituted nearly 11 percent of sequenced samples globally by mid-May, but there’s no evidence suggesting that it is more virulent than its predecessors.
“Despite some Western Pacific nations noting upticks in COVID-19 cases and hospitalizations, the symptoms associated with the new variant do not appear to be more severe than those of earlier variants,” the WHO stated. It seems that, at least for now, this variant isn’t rewriting the COVID-19 playbook.
Razor Blade Symptoms in Focus
Reports from both Chinese doctors and external health experts indicate that the ‘razor blade throat’ is a standout symptom of this new variant. Other symptoms include fever, headaches, fatigue, and coughing, which are all too familiar to those who have been tracking COVID-19 since its global emergence in 2020.
It’s worth noting that the credibility of local reporting from China can often be clouded by the Chinese Communist Party’s penchant for underreporting critical health data. Hence, insights from local healthcare providers, despite potential biases, may still shed light on the true nature of the ongoing situation.
Vaccine Efficacy and Public Health Outlook
The WHO has officially categorized the NB.1.8.1 variant as a “variant under monitoring,” assessing the global public health risk as low. They also contend that existing COVID-19 vaccines should maintain efficacy against symptomatic and severe manifestations of this variant. One can only hope that the vaccines live up to the hype!
In a somewhat controversial statement, U.S. Health Secretary Robert F. Kennedy Jr. declared last month that COVID-19 vaccinations are no longer recommended for healthy children and pregnant women. Is this a bold new strategy or a reckless gamble? Only time will tell.
The Associated Press and Alex Wu contributed to this report.
If you found this article interesting, please consider supporting traditional journalism
Since our inception 25 years ago in a humble basement in Atlanta, The Epoch Times has committed itself to delivering fact-based, award-winning journalism to millions. Our journalists have faced threats, arrests, and assaults, yet our commitment to independent reporting remains unshaken. We invite you to join our community for a limited-time introductory offer of just $1 per week and help celebrate the spirit of independent news.
